Compare ResMed Inc. (RMD) vs VanEck Vietnam ETF (VNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs VanEck Vietnam ETF — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.73B), while VanEck Vietnam ETF trades at $17.94. The key difference: ResMed Inc. pays a 1.2% dividend while VanEck Vietnam ETF pays none. Which is the better fit depends on your goals.
| RMD | VNM | |
|---|---|---|
Market Cap | $31.73B | — |
Sector | Health | Sector/Thematic |
52-Week High | $283.28 | $19.80 |
52-Week Low | $182.82 | $16.34 |
Enterprise Value | $31.08B | — |
Dividend Yield | 1.2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $221.05, down 3.2% on the day, with a bearish technical signal and key support at $218. The company reported strong Q4 2026 results, beating EPS estimates at $2.95, and maintains robust profitability with a 26.94% net income margin. Revenue growth remains solid, reaching $5.15B in 2025, though weak 2027 sales guidance has pressured the stock. A dividend of $0.66 is scheduled for payment in September 2026.
Outlook is mixed: strong fundamentals and a consensus price target of $235.70 suggest upside, but bearish technicals and investor lawsuits pose near-term risks. The stock offers value with a P/E of 21.19, yet competitive and regulatory challenges require monitoring for sustained growth.
VNM trades at $17.91, down 1.38% on the day, with technical indicators showing a bearish trend from moving averages while oscillators are neutral. The stock faces headwinds from its heavy concentration in Vietnamese real estate and financial sectors, as noted in recent analysis. Financial ratios are unavailable, limiting fundamental clarity.
The outlook is cautious due to sector-specific risks and underperformance relative to emerging markets. Opportunities exist if foreign institutional investment increases post-FTSE Russell reclassification, but investors must weigh macroeconomic volatility in Vietnam against potential long-term growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About VanEck Vietnam ETF
VNM is the first and largest U.S.-listed ETF providing targeted exposure to the Vietnamese equity market. It tracks the MarketVector™ Vietnam Local Index, which includes publicly traded companies that are locally incorporated in Vietnam. It serves as a liquid, transparent vehicle for investors looking to participate in Vietnam's transition into a global manufacturing hub and its long-term potential for emerging market reclassification.
Read more on VNM →
